BillionToOne, inventors of the patent-pending molecular counter platform, today announced it has closed its highly oversubscribed Series A funding round of $15 million with select global investors.
Read More —>
BillionToOne, inventors of the patent-pending molecular counter platform, today announced it has closed its highly oversubscribed Series A funding round of $15 million with select global investors.
Read More —>
Copyright © 2023 Pacific 8 Ventures